Stocks · Health care · Pharmaceutical Preparations

Bicara Therapeutics Inc.

BCAX Clue Score37
United States Fiscal year ends December CIK 0002023658 Results filed 11 Aug 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Ryan Cohlhepp
9 Jul 2026
President and COO
Sold on a plan
536
$29.00
$15.54K
Ryan Cohlhepp
22 Jan 2026
President and COO
Sold on a plan
3,828
$18.10
$69.30K
Ryan Cohlhepp
15 Jan 2026
President and COO
Sold on a plan
149
$18.02
$2.68K

What was left out

Form 4 filings counted 84
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 8
Sales on a Rule 10b5-1 plan 3
Sales straight out of an exercise 73
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 23,299,906
History held since 16 Sep 2024